Global Primary Cells Market
Segments - by Origins (Animal Primary Cells and Human Primary Cells), Types (Dermatocytes, Hematopoietic Cells, Gastrointestinal Cells, Heart Cells, Hepatocytes, Lung Cells, Cryopreserved Hepatocytes, Renal Cells, Fresh Hepatocytes, and Musculoskeletal Cells), End-users (Pharmaceutical & Biotechnology Companies and Medical, and Research Institutes), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The global primary cells market size was valued at USD 970 million 2020 and is expected to reach USD 1,613 million by 2025, expanding at a CAGR of 10.07% during the forecast period, 2021–2028. The growth of the market is attributed to increasing cancer research, growing prevalence of cancer, increasing investment in medicine research, rapid expansion in the biopharmaceutical and biotechnology industry, and growing need for monoclonal antibodies.
Primary human cells of the body are isolated from normal human body tissue or blood cells, using an enzymatic or mechanical method. The primary cells are able to maintain their fundamental cellular functions. This is one of the most important factors influencing their demand. 3D cell culture, virology, cancer research, stem cell therapy, and tissue restoration are few applications where primary cells are used.
Primary cell culture is beneficial for many research projects, which is anticipated to boost the market. Researchers are increasingly adopting primary cells to study cell biology and biochemistry, medication effects, cell signaling, and cell-pathogen interactions in 3D cell culture.
Market Trends, Drivers, Restraints, and Opportunities
Drivers
- Growing ongoing research for cancer & innovations in its treatment are estimated to fuel the market in the coming years. Use of primary cells is crucial in this research. These cells are useful for the development of cancer biomarkers and medication screening.
- Rising use of stem cell therapy to treat cancer and genetic abnormalities increased the demand for primary cells across the world, which is projected to boost the market during the forecast period.
- Rapid growth of technological advancements in healthcare and pharmaceutical sectors are spurring the market growth during the forecast period.
- Increasing demand for monoclonal antibodies, rising applications in genetic engineering and virology, and growing demand from developing countries are anticipated to fuel the market in the coming years.
Restraints
- Increasing concerns about primary cell culture contamination are projected to hinder the market growth during the forecast period. One of the most common problems in cell culture laboratories is primary cell culture contamination. Contaminated cells harm cell physiology and frequently result in inaccurate conclusions or the loss of unique cell lines.
Opportunity
- Rising usage of primary cells in 3D cultures for advance scientific research is estimated to create immense opportunities for market players. Primary cells are widely used in 3D cultures, as they produce more accurate results than regular cell lines.
Scope of Primary Cells Market Report
The report on the global primary cells market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Primary Cells Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2020 |
|
Historic Data |
2018–2019 |
|
Forecast Period |
2021–2028 |
|
Segmentation |
Origins (Animal Primary Cells and Human Primary Cells), Types (Dermatocytes, Hematopoietic Cells, Gastrointestinal Cells, Heart Cells, Hepatocytes, Lung Cells, Cryopreserved Hepatocytes, Renal Cells, Fresh Hepatocytes, and Musculoskeletal Cells), End-users (Pharmaceutical & Biotechnology Companies and Medical, and Research Institutes) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
ZenBio, Inc., Stem Cell Technologies, Promocell, ALLCells, Cell Applications, Inc., Sigma-Aldrich, Thermo Fisher Scientific, Cureline, American Type Culture Collection, Lonza Group, Cell Applications, Inc., Pelobiotech, Axol Bioscience Ltd, Cell Biologics, Inc., AG, and Creative Bioarray. |
Global Primary Cells Market Segment Insights
Based on origins, the market is divided into animal primary cells and human primary cells. In the primary cells market, the human primary cells segment holds the highest share. The human primary cell segment is expected to account for a key share of the market during the forecast period, due to growing use of human primary cells in the development of new cancer medicines and rising financing for cell therapy research and development.
In terms of types, the global primary cells market is segregated into dermatocytes, hematopoietic cells, gastrointestinal cells, heart cells, hepatocytes, lung cells, cryopreserved hepatocytes, renal cells, fresh hepatocytes, and musculoskeletal cells. The hematopoietic cells segment is anticipated to dominate the market during the forecast period, due to rising number of cell research projects and increasing pervasiveness of blood cancer.
Based on end-users, the market is segmented into pharmaceutical & biotechnology companies and medical and research institutes. The pharmaceutical & biotechnology companies’ segment is projected to represent a key share of the market during the forecast period, as these companies use primary cells as drug carriers and for cytotoxicity of new drugs.
On the basis of regions, the global primary cells market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market at a high CAGR during the forecast period. The regional market growth is attributed to increasing number of players releasing new human primary cells for research, expansion of the pharmaceutical and biotechnology sectors, growing focus on R&D, and rising prevalence of cancer in the region.
Segments
By Origins
- Animal Primary Cells
- Human Primary Cells
By Types
- Dermatocytes
- Hematopoietic Cells
- Gastrointestinal Cells
- Heart Cells
- Hepatocytes
- Lung Cells
- Cryopreserved Hepatocytes
- Renal Cells
- Fresh Hepatocytes
- Musculoskeletal Cells
By End-users
- Pharmaceutical & Biotechnology Companies
- Medical and Research Institutes
By Regions
- Asia Pacific
- North America
- Europe
- Latin America
- Middle East & Africa
By Key Players
- ZenBio Inc.
- Stem Cell Technologies
- Promocell
- ALLCells
- Cell Applications Inc.
- Sigma-Aldrich
- Thermo Fisher Scientific
- Cureline
- American Type Culture Collection
- Lonza Group
- Cell Applications Inc.
- Pelobiotech
- Axol Bioscience Ltd
- Cell Biologics Inc. AG
- Creative Bioarray
Competitive Landscape
Key players in the primary cells market include ZenBio, Inc., Stem Cell Technologies, Promocell, ALLCells, Cell Applications, Inc., Sigma-Aldrich, Thermo Fisher Scientific, Cureline, American Type Culture Collection, Lonza Group, Cell Applications, Inc., Pelobiotech, Axol Bioscience Ltd, Cell Biologics, Inc., AG, and Creative Bioarray.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Primary Cells Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Primary Cells Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Primary Cells Market - Supply Chain
4.5. Global Primary Cells Market Forecast
4.5.1. Primary Cells Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Primary Cells Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Primary Cells Market Absolute $ Opportunity
5. Global Primary Cells Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Primary Cells Market Size and Volume Forecast by Types
5.3.1. Dermatocytes
5.3.2. Hematopoietic Cells
5.3.3. Gastrointestinal Cells
5.3.4. Heart Cells
5.3.5. Hepatocytes
5.3.6. Lung Cells
5.3.7. Cryopreserved Hepatocytes
5.3.8. Renal Cells
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Primary Cells Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Primary Cells Market Size and Volume Forecast by End Users
6.3.1. Pharmaceutical & Biotechnology Companies
6.3.2. Medical and Research Institutes
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Primary Cells Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Primary Cells Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Primary Cells Demand Share Forecast, 2019-2026
8. North America Primary Cells Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Primary Cells Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Primary Cells Market Size and Volume Forecast by Types
8.4.1. Dermatocytes
8.4.2. Hematopoietic Cells
8.4.3. Gastrointestinal Cells
8.4.4. Heart Cells
8.4.5. Hepatocytes
8.4.6. Lung Cells
8.4.7. Cryopreserved Hepatocytes
8.4.8. Renal Cells
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. North America Primary Cells Market Size and Volume Forecast by End Users
8.7.1. Pharmaceutical & Biotechnology Companies
8.7.2. Medical and Research Institutes
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Primary Cells Demand Share Forecast, 2019-2026
9. Latin America Primary Cells Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Primary Cells Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Primary Cells Market Size and Volume Forecast by Types
9.4.1. Dermatocytes
9.4.2. Hematopoietic Cells
9.4.3. Gastrointestinal Cells
9.4.4. Heart Cells
9.4.5. Hepatocytes
9.4.6. Lung Cells
9.4.7. Cryopreserved Hepatocytes
9.4.8. Renal Cells
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Latin America Primary Cells Market Size and Volume Forecast by End Users
9.7.1. Pharmaceutical & Biotechnology Companies
9.7.2. Medical and Research Institutes
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Primary Cells Demand Share Forecast, 2019-2026
10. Europe Primary Cells Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Primary Cells Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Primary Cells Market Size and Volume Forecast by Types
10.4.1. Dermatocytes
10.4.2. Hematopoietic Cells
10.4.3. Gastrointestinal Cells
10.4.4. Heart Cells
10.4.5. Hepatocytes
10.4.6. Lung Cells
10.4.7. Cryopreserved Hepatocytes
10.4.8. Renal Cells
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Europe Primary Cells Market Size and Volume Forecast by End Users
10.7.1. Pharmaceutical & Biotechnology Companies
10.7.2. Medical and Research Institutes
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Primary Cells Demand Share Forecast, 2019-2026
11. Asia Pacific Primary Cells Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Primary Cells Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Primary Cells Market Size and Volume Forecast by Types
11.4.1. Dermatocytes
11.4.2. Hematopoietic Cells
11.4.3. Gastrointestinal Cells
11.4.4. Heart Cells
11.4.5. Hepatocytes
11.4.6. Lung Cells
11.4.7. Cryopreserved Hepatocytes
11.4.8. Renal Cells
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Asia Pacific Primary Cells Market Size and Volume Forecast by End Users
11.7.1. Pharmaceutical & Biotechnology Companies
11.7.2. Medical and Research Institutes
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Primary Cells Demand Share Forecast, 2019-2026
12. Middle East & Africa Primary Cells Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Primary Cells Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Primary Cells Market Size and Volume Forecast by Types
12.4.1. Dermatocytes
12.4.2. Hematopoietic Cells
12.4.3. Gastrointestinal Cells
12.4.4. Heart Cells
12.4.5. Hepatocytes
12.4.6. Lung Cells
12.4.7. Cryopreserved Hepatocytes
12.4.8. Renal Cells
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Middle East & Africa Primary Cells Market Size and Volume Forecast by End Users
12.7.1. Pharmaceutical & Biotechnology Companies
12.7.2. Medical and Research Institutes
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Primary Cells Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Primary Cells Market: Market Share Analysis
13.2. Primary Cells Distributors and Customers
13.3. Primary Cells Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. ZenBio Inc.
13.4.2. Stem Cell Technologies
13.4.3. Promocell
13.4.4. ALLCells
13.4.5. Cell Applications Inc.
13.4.6. Sigma-Aldrich
13.4.7. Thermo Fisher Scientific
13.4.8. Cureline
2. Assumptions and Acronyms Used
3. Research Methodology
4. Primary Cells Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Primary Cells Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Primary Cells Market - Supply Chain
4.5. Global Primary Cells Market Forecast
4.5.1. Primary Cells Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Primary Cells Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Primary Cells Market Absolute $ Opportunity
5. Global Primary Cells Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Primary Cells Market Size and Volume Forecast by Types
5.3.1. Dermatocytes
5.3.2. Hematopoietic Cells
5.3.3. Gastrointestinal Cells
5.3.4. Heart Cells
5.3.5. Hepatocytes
5.3.6. Lung Cells
5.3.7. Cryopreserved Hepatocytes
5.3.8. Renal Cells
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Primary Cells Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Primary Cells Market Size and Volume Forecast by End Users
6.3.1. Pharmaceutical & Biotechnology Companies
6.3.2. Medical and Research Institutes
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Primary Cells Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Primary Cells Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Primary Cells Demand Share Forecast, 2019-2026
8. North America Primary Cells Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Primary Cells Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Primary Cells Market Size and Volume Forecast by Types
8.4.1. Dermatocytes
8.4.2. Hematopoietic Cells
8.4.3. Gastrointestinal Cells
8.4.4. Heart Cells
8.4.5. Hepatocytes
8.4.6. Lung Cells
8.4.7. Cryopreserved Hepatocytes
8.4.8. Renal Cells
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. North America Primary Cells Market Size and Volume Forecast by End Users
8.7.1. Pharmaceutical & Biotechnology Companies
8.7.2. Medical and Research Institutes
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Primary Cells Demand Share Forecast, 2019-2026
9. Latin America Primary Cells Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Primary Cells Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Primary Cells Market Size and Volume Forecast by Types
9.4.1. Dermatocytes
9.4.2. Hematopoietic Cells
9.4.3. Gastrointestinal Cells
9.4.4. Heart Cells
9.4.5. Hepatocytes
9.4.6. Lung Cells
9.4.7. Cryopreserved Hepatocytes
9.4.8. Renal Cells
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Latin America Primary Cells Market Size and Volume Forecast by End Users
9.7.1. Pharmaceutical & Biotechnology Companies
9.7.2. Medical and Research Institutes
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Primary Cells Demand Share Forecast, 2019-2026
10. Europe Primary Cells Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Primary Cells Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Primary Cells Market Size and Volume Forecast by Types
10.4.1. Dermatocytes
10.4.2. Hematopoietic Cells
10.4.3. Gastrointestinal Cells
10.4.4. Heart Cells
10.4.5. Hepatocytes
10.4.6. Lung Cells
10.4.7. Cryopreserved Hepatocytes
10.4.8. Renal Cells
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Europe Primary Cells Market Size and Volume Forecast by End Users
10.7.1. Pharmaceutical & Biotechnology Companies
10.7.2. Medical and Research Institutes
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Primary Cells Demand Share Forecast, 2019-2026
11. Asia Pacific Primary Cells Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Primary Cells Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Primary Cells Market Size and Volume Forecast by Types
11.4.1. Dermatocytes
11.4.2. Hematopoietic Cells
11.4.3. Gastrointestinal Cells
11.4.4. Heart Cells
11.4.5. Hepatocytes
11.4.6. Lung Cells
11.4.7. Cryopreserved Hepatocytes
11.4.8. Renal Cells
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Asia Pacific Primary Cells Market Size and Volume Forecast by End Users
11.7.1. Pharmaceutical & Biotechnology Companies
11.7.2. Medical and Research Institutes
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Primary Cells Demand Share Forecast, 2019-2026
12. Middle East & Africa Primary Cells Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Primary Cells Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Primary Cells Market Size and Volume Forecast by Types
12.4.1. Dermatocytes
12.4.2. Hematopoietic Cells
12.4.3. Gastrointestinal Cells
12.4.4. Heart Cells
12.4.5. Hepatocytes
12.4.6. Lung Cells
12.4.7. Cryopreserved Hepatocytes
12.4.8. Renal Cells
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Middle East & Africa Primary Cells Market Size and Volume Forecast by End Users
12.7.1. Pharmaceutical & Biotechnology Companies
12.7.2. Medical and Research Institutes
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Primary Cells Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Primary Cells Market: Market Share Analysis
13.2. Primary Cells Distributors and Customers
13.3. Primary Cells Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. ZenBio Inc.
13.4.2. Stem Cell Technologies
13.4.3. Promocell
13.4.4. ALLCells
13.4.5. Cell Applications Inc.
13.4.6. Sigma-Aldrich
13.4.7. Thermo Fisher Scientific
13.4.8. Cureline
Our Clients
Related Reports
Some other reports from this category!
